Diabeton MV

Diabeton MV (Diabeton MR): nyocha 2 nke ndị dọkịta, nyocha nke ndị ọrịa 3, ntuziaka maka ojiji, analogues, infographics, ụdị mwepụta 1.

Nyocha ndị dọkịta banyere ọrịa shuga

Site n'ịkwụpụta ọrịa shuga, ọgwụ na-akwụ ụgwọ maka glycemia n'ụzọ zuru oke. Ntọhapụ a gbanwetụrụ na-enye ohere igbochi hypoglycemia, ya mere ọgwụ ahụ kwesịrị ekwesị maka ndị ọrịa agadi, yana ndị ọrịa nwere ọrịa nke usoro obi.

N’oge na-adịghị anya, mana ọ nwere ike bute ọrịa hypoglycemia.

Ana m a theụ ọgwụ ahụ ebe niile. Ọnụahịa ahụ nwere ezi uche, arụmọrụ dị oke mma.

A na-eji ọgwụ "Diabeton MV" n'ọtụtụ usoro nke 30 ma ọ bụ 60 mg. Edebere mbadamba ndenye ndị a. Ọgwụ nwere ezigbo arụmọrụ yana profaịlụ ọ bụla. Enweghị mmetụta ọ bụla, mmetụta nke ọgwụ ahụ na-amalite mgbe oge adịghị oke. Ọtọ nke ọma maka ịgwọ ọrịa shuga.

Nyocha nyocha nke ndị ọrịa n'ọrịa mamịrị MV

Di m nwere nnukwu shuga. Ruo ọtụtụ afọ, ha na-achọ ọgwụ ga-agbada shuga ya, ma nke kachasị mkpa, mee ka ọkwa ya dị ka ọ dị. Oge ọzọ ya na dibịa bekee, gwara anyị ọgwụ a “Diabeton MV”. Ka otu ọnwa gachara ọgwụ a, shuga laghachiri n'ọnọdụ nkịtị. Ugbu a di m nwere 8.2 mm. N'ezie, nke a bụ ọkwa dị elu. Mana ọ ka mma karịa 13-15 mm nke dị na mbụ.

N 'usoro ọgwụ shuga' nke 60 mg kwa ụbọchị, anaghị belata nke ọma. N'ụtụtụ, shuga 10-13 dị. Mgbe ahụ dọkịta ahụ mụbara usoro onunu ogwu ka 90 mg (1.5 tab). Ugbu a n'ụtụtụ, mgbe m tụtara shuga, ọ bụdị nke 6. Ekwesịrị m ikwu na ọtụtụ ihe ga-adabere ma m rubere isi na nri ahụ. Naanị otu ihe ahụ bụ 6 ka nsogbu iri nri adịghị. N'ezie, gbakwunye obere mmega ahụ.

Anọwo m na-ewere ya ruo otu afọ, mmetụta dị mma, a na-ahụta mmetụta na ọsọ. Nsonaazụ anaghị adị. Nnukwu usọbọ.

Ọgwụ Farmacology

Ngwunye ọgwụ hypoglycemic nke na-ahụ maka ọnya, ihe dị na usoro nke usoro nke n'ọgbọ nke abụọ. Na-akwalite mmiri ọgwụ insulin site na mkpụrụ ndụ nke akwara. Ọ na-eme ka ahụrịị anụ ahụ dị elu na insulin. N'ụzọ doro anya, ọ na-akpali ọrụ nke enzymes intracellular (karịchaa, akwara glycogen synthetase). Na-ebelata oge dị n'etiti oge iri nri rue mmalite insulin insulin. Weghachi mbido insulin nke mbụ, na-ebelata oke postprandial nke hyperglycemia.

Glyclazide na-ebelata nrapado platelet na nchịkọta, na-ebelata mmepe nke thrombus parietal, na -emekwa ọrụ fibrinolytic vaskụla. Normalizes vaskụla permeability. Ọ nwere ihe anti-atherogenic: ọ na-ebelata mkpokọta cholesterol zuru oke (Ch) na LDL-C n'ime ọbara, na-eme ka ịtawanye eleba anya nke HDL-C ma belata ọnụ ọgụgụ nke radicals n'efu. Na-egbochi mmepe nke microthrombosis na atherosclerosis. Ọ na - eme ka microcirculation dịkwuo mma. Na-ebelata akwara vaskụla na adrenaline.

Site na nephropathy na-arịa ọrịa mamịrị na iji gliclazide ruo ogologo oge, a na-achọpụta mbelata dị ukwuu na proteinuria.

Mlọ ọgwụ

Mgbe nchịkwa ọnụ gasịrị, ọ na-abanye n'ime ngwa ngwa. C_max n'ọbara ruru ihe ruru elekere 4 mgbe ị aụchara otu ọgwụ were 80 mg.

Njikọ protein protein Plasma bụ 94,2%. Ise_d - ihe dịka 25 l (0.35 l / n'arọ ahụ).

Ọ bụ metabolized na imeju na nguzobe nke 8 metabolites. Ihe metabolite bụ isi enweghị mmetụta hypoglycemic, kama ọ nwere mmetụta microcirculation.

Ndi_1/2 - Nkeji awa 12. Ọ na - apịpụta ihe kachasị site na akụrụ n'ụdị metabolites, ihe na-erughị 1% dị na mmamịrị ahụ agbanweghi.

Mpempe mwepụta

Mbadamba ndị a gbanwere wepụtara na-acha ọcha, na-acha odo odo, na-arụ ọrụ na akụkụ abụọ: na otu bụ akara nke ụlọ ọrụ ahụ, na nke ọzọ - "DIA30".

Ndị na-ahụ maka ihe: calcium hydrogen phosphate dihydrate, maltodextrin, hypromellose, magnesium stearate, anhydrous colloidal silicon dioxide.

30 PC - blisters (1) - ngwugwu nke kaadiboodu.
30 PC - blisters (2) - ngwugwu nke kaadiboodu.

Mmekorita

Mmetụta hypoglycemic nke gliclazide bụ nke a na-eji ya eme ihe na iji ya eme ihe na pyrazolone, salicylates, phenylbutazone, antibacterial sulfonamide ọgwụ, theophylline, caffeine, MAO inhibitors.

Ojiji nke beta-egbochi na-eme ka enwee ike ịbawanye hypoglycemia, ọ nwekwara ike ikpuchi tachycardia na ịma jijiji aka, njirimara nke hypoglycemia, ebe ịchafụ nwere ike ịba ụba.

N'iji oge nke gliclazide na acarbose, a na-ahụ mmetụta hypoglycemic na-eme ihe.

Cimetidine na-eme ka ịbawanye ụba nke gliclazide na plasma, nke nwere ike ibute nnukwu hypoglycemia (ịda mbà CNS, nsụhọ mmụọ).

Site na iji GCS n'otu oge (gụnyere usoro onunu ogwu maka iji mpụga), diuretics, barbiturates, estrogens, progesins, ọgwụ estrogen-progestogen jikọtara ọnụ, diphenin, rifampicin, mmetụta hypoglycemic nke glyclazide belatara.

Nsonaazụ

Site na usoro digestive: adịkarịghị - anorexia, ọgbụgbọ, vomiting, afọ ọsịsa, mgbu epigastric.

Site na usoro hemopoietic: n'ọnọdụ ụfọdụ - thrombocytopenia, agranulocytosis ma ọ bụ leukopenia, anaemia (nke a na-atụgharịkarị).

Site na usoro endocrine: nwere oke inyeju - hypoglycemia.

Mmeghachi omume nfụkasị: ọnya anụ ahụ, itching.

Diabetesdị ọrịa shuga 2dị nke abụọ na-enweghị ike nke usoro ọgwụgwọ nri, mmega ahụ na oke ibu.

Mgbochi nsogbu nke ụdị ọrịa shuga 2 nke ọrịa shuga: na-ebelata ihe ize ndụ nke microvascular (nephropathy, retinopathy) na nsogbu macrovaskụla (infarction myocardial, stroke).

Ntụziaka pụrụ iche

A na-eji Gliclazide gwọọ ọrịa mellitus na-abụghị insulin na-etinye ya na obere kalori, nri nwere obere carb.

N'oge ọgwụgwọ, ị kwesịrị ị na-enyocha ọkwa nke glucose n'ọbara na afọ na-enweghị nri na mgbe ị risịrị nri, na-agbanwe kwa ụbọchị na ọkwa glucose.

N'ihe banyere usoro ịwa ahụ ma ọ bụ mejupụta ọrịa shuga mellitus, ọ dị mkpa iburu n'uche ohere nke iji insulin insulin eme ihe.

Site na mmepe nke hypoglycemia, ọ bụrụ na onye ọrịa maara, a na-edenye glucose (ma ọ bụ ihe ngwọta shuga) n'ime. Ọ bụrụ na mmụọ amaghị, a na-edozi glucose intravenous ma ọ bụ glucagon sc, intramuscularly ma ọ bụ intraven. Mgbe ọ nwetasịrị, ọ dị mkpa inye onye ọrịa ahụ nri nwere carbohydrates iji zere ịmaliteghachi hypoglycemia.

N'iji oge nke gliclazide na verapamil, a chọrọ nlezianya nke ọkwa glucose ọbara, yana acarbose, jiri nlezianya na-agbazi ma na-agbazi usoro nchịkwa nke usoro hypoglycemic.

Ekwesighi iji gliclazide na cimetidine n'otu oge.